ImmuCell Corporation Investor Presentation August 2024

ImmuCell Corporation presented an investor overview in August 2024 covering company strategy, product lines including First Defense and Re-Tain, and financial performance. The presentation addresses manufacturing capacity expansion, market opportunity in subclinical mastitis treatment, and operational challenges including supply chain disruptions.